Beijing
permanent
Quality ManagementRegulatory CompliancecGMPBiologicsEquipment QualificationDocumentation ReviewRisk ManagementProject LeadershipFacility Acceptance Testing
About the job Sanofi has decided to invest into a new large state-of-the art facility for Insulin Drug Substance in Beijing, China. For this green field operation, we’re enhancing our legacy of excel...
April 2, 2026
View Details